Get a glimpse into our company and investor data—powered by the PitchBook Platform
A leukotriene C4 synthase inhibitor program. The project aims to develop drugs to treat respiratory disorders such as asthma and chronic obstructive pulmonary disease.
This information is reserved for PitchBook Platform users. To explore Orexo (OX-CLI Project)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.